OneroRx Launches Lower-Cost Diabetes Medication Brenzavvy
WEST DES MOINES, IA, UNITED STATES, June 1, 2026 /EINPresswire.com/ – OneroRx, a community-focused healthcare provider, announced the immediate availability of Brenzavvy (Bexagliflozin), a lower-cost SGLT2 inhibitor for adults with type 2 diabetes.
Approved by the FDA in 2023 and developed by TheracosBio, Brenzavvy helps improve blood glucose control while addressing a major barrier to care: affordability. As one of the most cost-effective options in its class, it aims to support better adherence and long-term outcomes.
“We understand the challenges of managing diabetes and are committed to providing affordable solutions,” Joseph Dunham said, Chairman and CEO of OneroRx. “From Brenzavvy to our Contonious Glucose Monitor (CGM) offerings, we’re helping patients take control of their health with confidence.”
TheracosBio CEO Brian Connelly added, “We are excited to partner with OneroRx to make low-cost, safe, and effective Brenzavvy available to more patients. The community-focused healthcare approach at OneroRx is a perfect fit with our mission to offer affordable therapeutics to those in need.”
Brenzavvy is now available at select OneroRx pharmacies, including:
Medicap Pharmacy, Urbandale IA, Sinks Pharmacy, Rolla MO, Lee’s Summit Pharmacy, Lee’s Summit MO, Local Health Pharmacy, Chicago IL, Juniper Pharmacy, St. Louis MO, and Willowbrook Pharmacy, Carmel IN.
Special Launch Offer
For a limited time, patients can receive $38 off a three-month supply. Patients should consult their pharmacist or healthcare provider to determine eligibility.
“We remain committed to expanding offerings and making healthcare more accessible,” Dunham added. “We thank our partners for helping create this affordable path to wellness.”
For more information or to find a participating pharmacy, visit https://www.onerorx.com/patient.
About OneroRx OneroRx provides affordable, high-quality pharmacy services to underserved communities, filling over 5 million prescriptions annually across 92 locations in eight states.
About TheracosBio Founded in 2004, TheracosBio develops affordable therapeutics for diseases with significant societal impact.
Craig Olson OneroRx Inc Visit us on social media: https://www.linkedin.com/company/onerorx
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.